Glenveigh Pharmaceuticals, LLC — Form D
Glenveigh Pharmaceuticals, LLC of CHATTANOOGA, TN, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-29. The offering totals $2.5M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-11-29
- Form: D
- Accession: 0001535853-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $250K
- Remaining: $2.3M
- Minimum investment: $100K
- Investors: 1
- Date of first sale: 2011-11-14
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-169367
Issuer
- Name: Glenveigh Pharmaceuticals, LLC
- CIK: 0001535853
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 401 CHESTNUT STREET, CHATTANOOGA, TN, 37402
- Phone: 423-243-3460
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Charles David Adair | Director | CHATTANOOGA, TN |
| Charles David Adair | Executive Officer | CHATTANOOGA, TN |
| Mark David Hackett | Director | Chattanooga, TN |
| Lizbeth David Kennedy-Thomas | Director | Dalton, GA |
| Richard C Proctor, Jr. | Director | Chattanooga, TN |
| Richard C Proctor, Jr. | Executive Officer | Chattanooga, TN |
| Richard R Becherer | Director | Chattanooga, TN |
| Ken David Couch | Director | Spartanburg, SC |
| William R Russell | Director | Chattanooga, TN |
Other filings by this issuer (1)
More